Company news
Nirvana Life Sciences Inc (CSE:NIRV.X) news
Nirvana Life Sciences Inc news releases on 6ix. Latest, Jan 29, 2024: Nirvana Life Sciences Inc. Announces Receipt of First North American Production of SOSA…
Press releases & updates
Nirvana Life Sciences Inc. Announces Receipt of First North American Production of SOSA, a Patented, WHO Approved, Herbal Treatment for Opiate Addiction
January 29, 2024
Nirvana Life Sciences Inc. announces agreement to acquire the licensed distributor of a Patented, WHO approved, herbal treatment for opiate addiction
November 21, 2022
Nirvana Life Sciences Inc. Deuterates 7-Hydroxymitragynine to Create D7-h, an Analogue that May Improve Research and Formulations using Kratom Derivatives
September 22, 2022
Nirvana Life Sciences Inc. Announces a Method for Producing MDMA that Reduces Manufacturing Time by Two Thirds
September 7, 2022
Nirvana Life Sciences Inc. Announces License for a Delivery System for Psychedelic APIs
July 6, 2022
Nirvana Life Sciences Announces Approval To Build Vancouver Facility From Health Canada
June 28, 2022
Nirvana Life Sciences announces filing of Patent for novel isolation of 4-PO-Psilocin Prodrug Compound
June 23, 2022
Nirvana Life Sciences Announces Patent Filing
June 9, 2022
Nirvana Life Sciences Announces Positive Results for Addiction Relapse Prevention from Their Latest Pre-Clinical Psychedelic Drug Study
June 2, 2022
Nirvana Life Sciences Inc. Announces the appointment of Andrew Samann to Advisory Board
April 5, 2022
NIRVANA ENTERS SUPPLY AGREEMENT WITH SYMERES
March 29, 2022